GENZYME CORP Deferred Tax Assets, Net of Valuation Allowance
GENZYME CORP had Deferred Tax Assets, Net of Valuation Allowance of $590.48 million as of 2010-12-31, per its 10-K filed 2011-03-01.
Discontinued › Notes › Income Taxes › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsNet · last filed 2011-03-01
- 2010-12-31: Deferred Tax Assets, Net of Valuation Allowance $590.48M.
- 2009-12-31: Deferred Tax Assets, Net of Valuation Allowance $555.24M.
| Period end | Deferred Tax Assets, Net of Valuation Allowance |
|---|---|
| 2010-12-31 | $590.48M 10-K · filed 2011-03-01 |
| 2009-12-31 | $555.24M 10-K · filed 2011-03-01 |